ENST00000264275.9:c.-27+421T>G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000264275.9(CASP8):​c.-27+421T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.403 in 151,822 control chromosomes in the GnomAD database, including 12,995 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.40 ( 12995 hom., cov: 30)

Consequence

CASP8
ENST00000264275.9 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.641

Publications

6 publications found
Variant links:
Genes affected
CASP8 (HGNC:1509): (caspase 8) This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes composed of a prodomain, a large protease subunit, and a small protease subunit. Activation of caspases requires proteolytic processing at conserved internal aspartic residues to generate a heterodimeric enzyme consisting of the large and small subunits. This protein is involved in the programmed cell death induced by Fas and various apoptotic stimuli. The N-terminal FADD-like death effector domain of this protein suggests that it may interact with Fas-interacting protein FADD. This protein was detected in the insoluble fraction of the affected brain region from Huntington disease patients but not in those from normal controls, which implicated the role in neurodegenerative diseases. Many alternatively spliced transcript variants encoding different isoforms have been described, although not all variants have had their full-length sequences determined. [provided by RefSeq, Jul 2008]
CASP8 Gene-Disease associations (from GenCC):
  • autoimmune lymphoproliferative syndrome type 2B
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.481 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000264275.9. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CASP8
NM_001228.5
c.-27+421T>G
intron
N/ANP_001219.2
CASP8
NM_001400648.1
c.-27+421T>G
intron
N/ANP_001387577.1
CASP8
NM_001400651.1
c.-27+421T>G
intron
N/ANP_001387580.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CASP8
ENST00000264275.9
TSL:1
c.-27+421T>G
intron
N/AENSP00000264275.5
CASP8
ENST00000392258.7
TSL:1
c.-27+421T>G
intron
N/AENSP00000376087.3
CASP8
ENST00000471383.5
TSL:1
n.250+421T>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.403
AC:
61198
AN:
151704
Hom.:
12997
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.296
Gnomad AMI
AF:
0.414
Gnomad AMR
AF:
0.384
Gnomad ASJ
AF:
0.455
Gnomad EAS
AF:
0.223
Gnomad SAS
AF:
0.241
Gnomad FIN
AF:
0.465
Gnomad MID
AF:
0.313
Gnomad NFE
AF:
0.486
Gnomad OTH
AF:
0.429
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.403
AC:
61194
AN:
151822
Hom.:
12995
Cov.:
30
AF XY:
0.396
AC XY:
29399
AN XY:
74178
show subpopulations
African (AFR)
AF:
0.295
AC:
12229
AN:
41404
American (AMR)
AF:
0.383
AC:
5848
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.455
AC:
1576
AN:
3462
East Asian (EAS)
AF:
0.222
AC:
1149
AN:
5170
South Asian (SAS)
AF:
0.241
AC:
1158
AN:
4802
European-Finnish (FIN)
AF:
0.465
AC:
4877
AN:
10498
Middle Eastern (MID)
AF:
0.310
AC:
91
AN:
294
European-Non Finnish (NFE)
AF:
0.486
AC:
32985
AN:
67912
Other (OTH)
AF:
0.429
AC:
903
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1770
3540
5310
7080
8850
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
572
1144
1716
2288
2860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.443
Hom.:
1908
Bravo
AF:
0.397
Asia WGS
AF:
0.222
AC:
774
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
1.7
DANN
Benign
0.48
PhyloP100
-0.64
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12620010; hg19: chr2-202099256; API